Tsukuba, Japan

Susumu Maruyama

This inventor holds 1 USPTO granted patent. Top assignees: Agency of Industrial Science and Technology, Showa Sangyo Co., Ltd.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susumu Maruyama. Retrieved from https://idiyas.com/inventor/susumu-maruyama-1no8932z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susumu Maruyama: Innovator in Oligopeptide Research

Introduction

Susumu Maruyama is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of oligopeptides and their applications as angiotensin-converting enzyme inhibitors.

Latest Patents

Maruyama holds a patent for a series of oligopeptides, which include compounds such as L-Tyr-L-Val, L-Leu-L-Tyr, and L-Phe-L-Tyr, among others. These compounds are derived from corn protein α-zein and have potential applications in hypotensive treatments. His patent also covers various acid addition salts of these peptides, showcasing a diverse range of chemical formulations.

Career Highlights

Throughout his career, Maruyama has worked with prominent organizations, including the Agency of Industrial Science and Technology and Showa Sangyo Co., Ltd. His work has been instrumental in advancing the understanding of peptide-based therapies.

Collaborations

Maruyama has collaborated with esteemed colleagues such as Hideoki Tanaka and Hidekatsu Maeda. These partnerships have contributed to the innovative research and development of his patented compounds.

Conclusion

Susumu Maruyama's contributions to the field of oligopeptides highlight his role as a significant inventor in biochemistry. His patented innovations continue to influence research and potential therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…